Difference between revisions of "Antiepileptic medication side-effects"

(Created page with "- Patients with previous psychiatric history are more likely to discontinue AEDs due to psychiatric side-effects 77 - Patients with low socioeconomic status and recreational...")
 
Line 1: Line 1:
−
- Patients with previous psychiatric history are more likely to discontinue AEDs due to psychiatric side-effects 77
+
- Patients with previous psychiatric history are more likely to discontinue AEDs due to psychiatric side-effects (Stephen, Wishart, and Brodie, 2017)
  
−
- Patients with low socioeconomic status and recreational drug use also were more likely to develop psychiatric side-effects from levetiracetam 79
+
- Patients with low socioeconomic status and recreational drug use also were more likely to develop psychiatric side-effects from levetiracetam (Josephson et al, 2019)
  
−
- In general, sodium channel blockers are less likely to cause neuropsychiatric side-effects 77
+
- In general, sodium channel blockers are less likely to cause neuropsychiatric side-effects (Stephen, Wishart, and Brodie, 2017)
  
−
- Specific antiseizure medication effects:
 
  
−
:- Carbamazepine – lower likelihood of psychiatric side-effects
+
Specific antiseizure medication effects:
  
−
:- Clobazam – can be disinhibiting or agitating
+
* Carbamazepine – lower likelihood of psychiatric side-effects
 +
* Clobazam – can be disinhibiting or agitating
 +
* Eslicarbazepine – lower likelihood of psychiatric and cognitive side-effects
 +
* Felbamate
 +
* Gabapentin – lower likelihood of psychiatric and cognitive side-effects
 +
* Lacosamide – lower likelihood of cognitive side-effects
 +
* Lamotrigine – lower likelihood of psychiatric and cognitive side-effects
 +
* Levetiracetam – higher likelihood of psychiatric (depression, aggression, irritability, anxiety, insomnia; less common – psychosis, mania, suicidal ideation) and cognitive side-effects 79–81
 +
* Oxcarbazepine – lower likelihood of psychiatric side-effects
 +
* Perampanel – higher likelihood of psychiatric side-effects (aggression, anger, anxiety), dizziness (most common), and somnolence, fatigue, confusion (Brodie et al, 2016; Hansen et al 2018; Krauss et al, 2012)
 +
* Phenobarbital – higher likelihood of psychiatric and cognitive side-effects
 +
* Pregabalin – lower likelihood of psychiatric side-effects
 +
* Primidone – higher likelihood of cognitive side-effects
 +
* Rufinamide – lower likelihood of cognitive side-effects
 +
* Tiagabine – lower likelihood of cognitive side-effects
 +
* Topiramate – higher likelihood of psychiatric (depression, irritability, aggressive behavior, anxiety) and cognitive side-effects (bradyphrenia, expressive language disorder, confusion, disorientation) (Hansen et al, 2018; Kruass et al 2012)
 +
* Valproic acid – lower likelihood of psychiatric side-effects
 +
* Vigabatrin – higher likelihood of psychiatric side-effects
 +
* Zonisamide – higher likelihood of psychiatric and cognitive side-effects
  
−
:- Eslicarbazepine – lower likelihood of psychiatric and cognitive side-effects
+
- Often if aggressive behaviors develop or worsen in the setting of AED initiation or uptitration, often the aggressive behavior can only be stopped by discontinuing the AED (though one may consider downtitrating first and observing) (Brodie et al, 2016)
  
−
:- Felbamate
 
  
−
:- Gabapentin – lower likelihood of psychiatric and cognitive side-effects
+
== References ==
  
−
:- Lacosamide – lower likelihood of cognitive side-effects
+
Brodie, M. J. et al. Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review. Pharmacol. Rev. 68, 563–602 (2016). https://pubmed.ncbi.nlm.nih.gov/27255267/
  
−
:- Lamotrigine – lower likelihood of psychiatric and cognitive side-effects
+
Krauss, G. L. et al. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology 78, 1408–1415 (2012). https://pubmed.ncbi.nlm.nih.gov/22517103/
  
−
:- Levetiracetam – higher likelihood of psychiatric (depression, aggression, irritability, anxiety, insomnia; less common – psychosis, mania, suicidal ideation) and cognitive side-effects 79–81
+
Hansen, C. C., Ljung, H., Brodtkorb, E. & Reimers, A. Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel. Behav. Neurol. 2018, 2064027 (2018). https://pubmed.ncbi.nlm.nih.gov/30581496/
−
o Oxcarbazepine – lower likelihood of psychiatric side-effects
 
−
o Perampanel – higher likelihood of psychiatric side-effects (aggression, anger, anxiety), dizziness (most common), and somnolence, fatigue, confusion 80–82
 
−
o Phenobarbital – higher likelihood of psychiatric and cognitive side-effects
 
−
o Pregabalin – lower likelihood of psychiatric side-effects
 
−
o Primidone – higher likelihood of cognitive side-effects
 
−
o Rufinamide – lower likelihood of cognitive side-effects
 
−
o Tiagabine – lower likelihood of cognitive side-effects
 
−
o Topiramate – higher likelihood of psychiatric (depression, irritability, aggressive behavior, anxiety) and cognitive side-effects (bradyphrenia, expressive language disorder, confusion, disorientation) 80,81
 
−
o Valproic acid – lower likelihood of psychiatric side-effects
 
−
o Vigabatrin – higher likelihood of psychiatric side-effects
 
−
o Zonisamide – higher likelihood of psychiatric and cognitive side-effects
 
  
−
- Often if aggressive behaviors develop or worsen in the setting of AED initiation or uptitration, often the aggressive behavior can only be stopped by discontinuing the AED (though one may consider downtitrating first and observing) 80
+
Josephson, C. B. et al. Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription. JAMA Neurol. 76, 440–446 (2019). https://pubmed.ncbi.nlm.nih.gov/30688969/
 +
 
 +
Stephen, L. J., Wishart, A. & Brodie, M. J. Psychiatric side effects and antiepileptic drugs: Observations from prospective audits. Epilepsy Behav. 71, 73–78 (2017) https://pubmed.ncbi.nlm.nih.gov/28551500/

Revision as of 09:27, 12 June 2021

- Patients with previous psychiatric history are more likely to discontinue AEDs due to psychiatric side-effects (Stephen, Wishart, and Brodie, 2017)

- Patients with low socioeconomic status and recreational drug use also were more likely to develop psychiatric side-effects from levetiracetam (Josephson et al, 2019)

- In general, sodium channel blockers are less likely to cause neuropsychiatric side-effects (Stephen, Wishart, and Brodie, 2017)


Specific antiseizure medication effects:

  • Carbamazepine – lower likelihood of psychiatric side-effects
  • Clobazam – can be disinhibiting or agitating
  • Eslicarbazepine – lower likelihood of psychiatric and cognitive side-effects
  • Felbamate
  • Gabapentin – lower likelihood of psychiatric and cognitive side-effects
  • Lacosamide – lower likelihood of cognitive side-effects
  • Lamotrigine – lower likelihood of psychiatric and cognitive side-effects
  • Levetiracetam – higher likelihood of psychiatric (depression, aggression, irritability, anxiety, insomnia; less common – psychosis, mania, suicidal ideation) and cognitive side-effects 79–81
  • Oxcarbazepine – lower likelihood of psychiatric side-effects
  • Perampanel – higher likelihood of psychiatric side-effects (aggression, anger, anxiety), dizziness (most common), and somnolence, fatigue, confusion (Brodie et al, 2016; Hansen et al 2018; Krauss et al, 2012)
  • Phenobarbital – higher likelihood of psychiatric and cognitive side-effects
  • Pregabalin – lower likelihood of psychiatric side-effects
  • Primidone – higher likelihood of cognitive side-effects
  • Rufinamide – lower likelihood of cognitive side-effects
  • Tiagabine – lower likelihood of cognitive side-effects
  • Topiramate – higher likelihood of psychiatric (depression, irritability, aggressive behavior, anxiety) and cognitive side-effects (bradyphrenia, expressive language disorder, confusion, disorientation) (Hansen et al, 2018; Kruass et al 2012)
  • Valproic acid – lower likelihood of psychiatric side-effects
  • Vigabatrin – higher likelihood of psychiatric side-effects
  • Zonisamide – higher likelihood of psychiatric and cognitive side-effects

- Often if aggressive behaviors develop or worsen in the setting of AED initiation or uptitration, often the aggressive behavior can only be stopped by discontinuing the AED (though one may consider downtitrating first and observing) (Brodie et al, 2016)


References

Brodie, M. J. et al. Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review. Pharmacol. Rev. 68, 563–602 (2016). https://pubmed.ncbi.nlm.nih.gov/27255267/

Krauss, G. L. et al. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology 78, 1408–1415 (2012). https://pubmed.ncbi.nlm.nih.gov/22517103/

Hansen, C. C., Ljung, H., Brodtkorb, E. & Reimers, A. Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel. Behav. Neurol. 2018, 2064027 (2018). https://pubmed.ncbi.nlm.nih.gov/30581496/

Josephson, C. B. et al. Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription. JAMA Neurol. 76, 440–446 (2019). https://pubmed.ncbi.nlm.nih.gov/30688969/

Stephen, L. J., Wishart, A. & Brodie, M. J. Psychiatric side effects and antiepileptic drugs: Observations from prospective audits. Epilepsy Behav. 71, 73–78 (2017) https://pubmed.ncbi.nlm.nih.gov/28551500/

Retrieved from "https://ectopicbrain.bwh.harvard.edu/index.php?title=Antiepileptic_medication_side-effects&oldid=164"